MoneyWorks4Me

A decent increase of about 29.84% in the sales to Rs. 1863.84 millions was observed for the quarter ended March 2023. The sales figure stood at Rs. 1435.44 millions during the year-ago period.Good  Net Profit growth of 27.63% reported above the corresponding previous quarter figure of Rs. 212.80 millions to Rs. 271.59 millioins.OP of the company witnessed a marginal growth to 406.44 millions from 259.63 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1863.84 1435.44 29.84 6167.34 5201.35 18.57 6167.34 5201.35 18.57
Other Income -1.74 1.76 -198.86 43.20 27.62 56.41 43.20 27.62 56.41
PBIDT 406.44 259.63 56.55 1269.82 1079.38 17.64 1269.82 1079.38 17.64
Interest 5.94 5.89 0.85 24.14 64.07 -62.32 24.14 64.07 -62.32
PBDT 400.50 253.74 57.84 1245.68 1015.31 22.69 1245.68 1015.31 22.69
Depreciation 34.27 31.12 10.12 123.42 100.80 22.44 123.42 100.80 22.44
PBT 366.23 222.62 64.51 1122.26 914.51 22.72 1122.26 914.51 22.72
TAX 94.64 9.82 863.75 288.82 195.04 48.08 288.82 195.04 48.08
Deferred Tax 5.96 0.47 1168.09 25.05 27.83 -9.99 25.05 27.83 -9.99
PAT 271.59 212.80 27.63 833.44 719.47 15.84 833.44 719.47 15.84
Equity 364.37 364.37 0.00 364.37 364.37 0.00 364.37 364.37 0.00
PBIDTM(%) 21.81 18.09 20.56 20.59 20.75 -0.78 20.59 20.75 -0.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..